[Retracted] The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma

Table 3

The relationship between SPHK1 expression and clinicopathological factors in endometrial carcinoma.

Clinicopathological factors	Number	SPHK1 expression		χ^2	P
		+	−
	86	69	17
Age				0.575	0.448
<50 years old	24	18	6
≥50 years old	62	51	11
Pathological types				24.632	<0.001
Adenocarcinoma	41	40	1
Serous type	23	19	4
Clear cell type	13	6	7
Other types	9	4	5
FIGO staging				4.463	0.035
I-II	63	54	9
III-IV	23	15	8
Degree of differentiation				0.556	0.757
Highly differentiated	26	22	4
Moderately differentiated	30	23	7
Poorly differentiated	30	24	6
Muscle infiltration				1.316	0.251
<1/2	51	43	8
≥1/2	35	26	9
Lymph node metastasis				6.657	0.010
Yes	58	51	7
No	28	18	10
ER				4.986	0.026
Positive	30	28	2
Negative	56	41	15
PR				6.561	0.010
Positive	39	36	3
Negative	47	33	14